An experimental vaccine has proved it can greatly enhance immunity against tuberculosis (TB) in people who were previously vaccinated with the far-from-perfect bacille Calmette-Guérin (BCG) vaccine for TB. BCG was first used more than 80 years ago. It provides some protection in children but not adults.
The scientists gave the new vaccine to 17 volunteers who had received the BCG vaccine in the past—as recently as within a year or as long as 38 years ago. The team also enrolled 25 people who had never received a BCG shot. Of these, 14 received the new vaccine and 11 got a BCG shot.
In the November Nature Medicine, the researchers report that in the group with a history of BCG vaccination, the new vaccine elicited a potent army of immune system T cells that cranked out a compound called interferon-gamma. This protein activates other immune cells, called macrophages, to stand guard against Mycobacterium tuberculosis, the microbe that causes TB.
Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.